Abstract
Granular activated carbon (GAC) filters can be used to reduce emissions of organic micropollutants via municipal wastewater, but it is still uncertain to which extent biological degradation contributes to their removal in GAC filters. 14C-labeled organic micropollutants were therefore used to distinguish degradation from adsorption in a GAC-filter media with associated biofilm. The rates and extents of biological degradation and adsorption were investigated and compared with other biofilm systems, including a moving bed biofilm reactor (MBBR) and a sand filter, by monitoring 14C activities in the liquid and gas phases. The microbial cleavage of ibuprofen, naproxen, diclofenac, and mecoprop was confirmed for all biofilms, based on the formation of 14CO2, whereas the degradation of 14C-labeled moieties of sulfamethoxazole and carbamazepine was undetected. Higher degradation rates for diclofenac were observed for the GAC-filter media than for the other biofilms. Degradation of previously adsorbed diclofenac onto GAC could be confirmed by the anaerobic adsorption and subsequent aerobic degradation by the GAC-bound biofilm. This study demonstrates the potential use of 14C-labeled micropollutants to study interactions and determine the relative contributions of adsorption and degradation in GAC-based treatment systems.
Keywords: pharmaceuticals, 14C-labeling, granular activated carbon, biofilms, transformation
Short abstract
14C-labeling is applied in a new approach to confirm degradation of micropollutants in GAC-filter 16 media with potential to optimize future filter design.
1. Introduction
Adsorption onto activated carbon is one option for the abatement of organic micropollutants in municipal wastewater. Activated carbon can be applied in powdered (PAC) or granular (GAC) form, depending on the desired treatment configuration.1,2 GAC has particle sizes that are 10–100-fold larger than those in PAC and is more susceptible to mass transfer limitations, such as pore-blocking effects.3,4 Further, GAC filters are typically operated over long periods, allowing the colonization of microorganisms,5 which inevitably results in biofilm formation on the surfaces of GAC particles.
The presence of biofilms on GAC limits the transport of the substrate to the carbon surface,6 which could impact the choice of relevant empty bed contact times (EBCTs) for the filter. At the same time, the presence of biofilms allows for the potential long-term degradation of dissolved organic matter7 and micropollutants,8 which could lead to a partial bioregeneration of the activated carbon adsorption capacity.9,10
The large number of bed volumes that can be treated by GAC filters without deteriorating removal of certain organic micropollutants has raised the question of whether biological degradation contributes to long-term GAC-filter performance.8,11,12 However, assessing the degradation that occurs in GAC filters is challenging due to the potential adsorption of target micropollutants and their transformation products. The differentiation between biological degradation and adsorption in GAC filters, based on influent–effluent measurements of parent compounds, has been reported to be limited.13
Thus far, the contributions of degradation by GAC biofilms to the overall micropollutant removal process have mainly been estimated by comparing removal efficiencies for biologically activated GAC filters with those of sterilized GAC filters.14−16 Although this approach has illustrated the enhanced removal of several substances by biologically active GAC filters, this method does not necessarily allow for the strict separation between adsorption and biodegradation.14
The use of 14C-labeled micropollutants enables adsorption to be separated from degradation because only the latter contributes to the formation of 14CO2. The simultaneous tracking of 14C decay in the water and gas phases (using CO2-traps) has been used to study the biological degradation of organic micropollutants in wastewater17,18 and drinking water.19 The approach has further been used to demonstrate biodegradation and bioregeneration in GAC-filter columns20,21 and the potential for increased adsorption of nonbiodegradable compounds through the degradation of biodegradable compounds in two-component systems.22 Based on these findings, it appears possible to use 14C-labeling to study the degradation of organic micropollutants in wastewater in contact with GAC-filter media.
Therefore, the objective of this study was to use 14C-labeled micropollutants to investigate the adsorption and degradation of selected micropollutants in contact with a mature GAC-filter media and to compare the biodegradation potential of GAC-bound biofilms with those from other biofilm and suspended growth processes in a comprehensive set of batch experiments.
2. Materials and Methods
2.1. Media for Batch Experiments
Laboratory-based experiments were performed on three types of biofilm media: a GAC-filter media, a sand filter media, and carriers from a moving bed biofilm reactor (MBBR). The degradation capacities of each medium were further compared with their corresponding behaviors in an activated sludge process. The biomass media originated from two Swedish wastewater treatment plants (WWTPs), Klippan WWTP and Kristianstad WWTP, and a pilot plant that was operated at Kristianstad WWTP. Overviews of the two treatment plants are provided in Figure 1 and detailed in the Supporting Information (Section S1).
Figure 1.
Overview of wastewater treatment plants, including the pilot plant at Kristianstad WWTP.
The pilot plant at Kristianstad WWTP treats postprecipitated wastewater and consists of a sand filter and a subsequent GAC filter. The filters are identical in size, 1 m3 each, and are operated in downflow mode, with EBCTs of 30 min each. The GAC-filter media was Aquasorb 5000, 8′30 mesh (2.36–0.60 mm, Jacobi), with a specific surface area, according to the Brunauer–Emmett–Teller (BET) theory, of 1200 m2/g. At the time of initial experiments with the GAC-filter media, the filter had treated a total of 37 500 bed volumes.
Sand and GAC media were retrieved from the tops of respective filters at the pilot plant, operated at Kristianstad WWTP. To separate the media from the suspended biomass that originated from previous treatment steps, the sand and GAC media were repeatedly washed with effluent pilot wastewater, until the water phase was visibly clear of all particles. The sand and GAC media were stored (<48 h) in effluent wastewater at 8 °C until the start of the experiment. Activated sludge from Kristianstad WWTP and carriers from Klippan WWTP were retrieved the day before the start of the experiment and were aerated overnight.
2.2. Micropollutant Selection
Six 14C-labeled micropollutants with varying physicochemical properties were selected (Figure 2): Mecoprop [ring-u-14C] and sulfamethoxazole [phenyl ring-u-14C], from Izotop (Hungary); and ibuprofen [RS-carboxyl-14C], naproxen [O-methyl-14C], diclofenac [carboxyl-14C], and carbamazepine [carbonyl-14C], from Hartmann Analytics (Germany). All 14C positioning was chosen based on commercial availability. The radiochemical and chemical purities were >98%.
Figure 2.
Investigated micropollutants with the 14C-labeling indicated by blue circles.
2.3. Adsorption and Degradation Experiments
The adsorption and degradation experiments (Table 1) were performed in 500 mL glass bottles containing 150 mL biologically treated and filtered (0.45 μm cellulose nitrate, Whatman) wastewater, the various tested media (sand, GAC, carriers, or activated sludge), and 14C-labeled micropollutants. Each micropollutant was studied separately in a biologically active reactor with a corresponding heat-treated (85 °C, 60 min) control and a background control (containing only filtered wastewater). The biologically treated wastewater used for the experiments was retrieved from a separate plant (Lundåkra WWTP), with stable effluent nitrogen and chemical oxygen demand (COD) concentrations, as described elsewhere,23 to allow for a better comparison between media. The filtered wastewater added to the reactors was adjusted to pH 7.0, using 10 mM NaH2PO4 buffer (adjusted with 1 M NaOH), and saturated with oxygen (8–9 mg/L) to prevent anoxic conditions. 14C-labeled micropollutants were added at 1 μCi/L, corresponding to concentrations of approximately 6 μg/L mecoprop, 13 μg/L sulfamethoxazole, 4 μg/L ibuprofen, 5 μg/L naproxen, 5 μg/L diclofenac, and 11 μg/L carbamazepine.
Table 1. Overview of Treatment Conditions and the Experimental Setup.
After the addition of the biomass media, the reactors were sealed immediately with a rubber septum and incubated at 20 °C, with agitation at 150 rpm, for 5 days. To capture formed 14CO2, a glass tube that contained 25 mL of NaOH (0.1 M) was fixed inside the glass bottle, using a 3D-printed holder. Dissolved oxygen (DO) contents and pH were determined in 14C-free controls to ensure aerobic conditions (DO > 3 mg O2/L) and neutral pH (7.0–7.4). A more detailed summary of the experimental conditions is provided in Table S1.
Samples from the water phase (1 mL) and the NaOH trap (0.5 mL) were retrieved at regular intervals, through a rubber septum and using hypodermic needles, and were transferred to Eppendorf tubes. To separate the remaining biomass media, water phase samples were immediately centrifugated at 13 000 rpm for 5 min, followed by the transfer of supernatants (0.8 mL) to new Eppendorf tubes.
2.4. Degradation of Previously Adsorbed Micropollutants
To further study the interaction between adsorption and degradation, a variation of the previous experiment was designed. During this experiment, the wastewater that was used in the reactor was first purged with N2 gas to deplete oxygen, <0.1 mg O2/L. Using the same setup as described for the previous experiment, GAC was then allowed to adsorb 14C-labeled micropollutants for 24 h, under anaerobic/anoxic conditions, to minimize degradation. After the 24 h anoxic/anaerobic period, samples were taken from the water phase and the CO2 trap to estimate the extent of GAC adsorption. The preloaded GAC from the anoxic/anaerobic incubation was then separated from the wastewater by carefully decanting the water. Aerated wastewater, >8 mg O2/L, and new CO2 traps were then introduced to the reactors, before sealing and incubation as described for the previous experiment (5 days, 20 °C at 150 rpm).
2.5. Analysis
The amount of 14C originating β-decay was quantified by liquid scintillation counting (Tri-Carb 4910 TR, PerkinElmer). Portions of the samples (0.2 mL of the NaOH trap samples and 0.4 mL of the liquid samples) were mixed with a scintillation cocktail (Hionic-Flour, PerkinElmer), at a total volume of 4 mL, after which the mean numbers of counts per minute (over 5 min) were recorded. The background radiation values measured for wastewater and NaOH (mean of five samples) were subtracted from each sample value.
The main parameters of the biologically treated wastewater samples were measured after filtration (0.45 μm cellulose nitrate, Whatman). The spectrophotometric determination of concentrations was performed on a Hach-Lange DR 2800 using Hach-Lange cuvettes: chemical oxygen demand (COD, LCK 1414), total organic carbon (TOC, LCK 385), NH4-N (LCK 303), and NO3-N (LCK 339). Ultraviolet (UV) absorbance, at 254 nm (UVA254), was recorded (5 cm quartz cuvettes) using a UV spectrophotometer (Dr6000, Hach).
2.6. Biomass Estimation
A target biomass reactor concentration of 1.2 g of volatile solids (VS)/L was selected for the sand filter media and carriers, allowing oxic conditions, >3 mg O2/L, to prevail during the 5 day incubation. For the sand filter media, the VS concentration was determined by the dry weight difference before and after burning (550 °C, 60 min). For the carriers, the VS concentration was estimated based on the VS to total solids (TS) ratio and the amount of TS on the carriers. TS concentrations were first determined as the differences in carrier dry weights (105 °C) before and after the careful biofilm removal. The VS-to-TS ratio was then determined by burning the abraded and dried biofilm. For the activated sludge, the biomass concentration was determined as suspended solids (SS) and volatile suspended solids (VSS).
In the GAC experiments, the relative amounts of biomass could not be determined; therefore, a total of four GAC concentrations (0.8, 3.5, 12, and 51 gTS/L) were tested. The lowest dose (0.8 g/L), thus, corresponded to a total weight (biomass + GAC) below the concentrations (1.2 gVS/L or 1.4 gVSS/L) that were used for the other biomass media. Specific biomass/media concentrations were estimated based on 3–5 replicates and are shown in Table S1.
3. Results and Discussion
The rates and extent of biological degradation and adsorption in GAC-filter media were investigated and compared with other biofilm systems using 14C-labeled organic micropollutants.
3.1. Incubation Experiments
3.1.1. Sand Filter Media and Carrier-Attached Biofilm
In biological incubations containing biofilms, the removal of nonvolatile micropollutants can occur through adsorption and degradation via both biotic and abiotic pathways. However, background control experiments using 0.45 μm filtered wastewater (Figure S1) demonstrated negligible changes in 14C activities in the liquid and gas phases, which suggested that abiotic transformations occurring in the water phase, as well as biological transformation by microorganisms not retained by the 0.45 μm filtration, have minor influences on the 14C mass balance. The lack of 14CO2 formation in heat-treated controls (Figure S2) also suggested a negligible abiotic transformation induced by reactive surface functionality present on solids. The minor concentration changes that occurred in the liquid phases of heat-treated controls (Figure S2) further indicated negligible adsorption, as expected from low-solid, water partitioning coefficients for suspended sludge of <80 L/kgSS24,25 and the applied biomass concentrations, <2 g biomass/L (Table S1).
In the incubations with biologically active carrier and sand filter media, the decreasing 14C activities in the liquid phase were accompanied by the formation of 14CO2 (Figure 3). The phase-transfer rates were comparable for both the carriers and the sand filter media. The highest rates were observed for ibuprofen and naproxen, followed by mecoprop, diclofenac, sulfamethoxazole, and carbamazepine.
Figure 3.
Partitioning of 14C activities between liquid phases (blue) and CO2 traps (red) for six 14C-labeled micropollutants in contact with MBBR carriers (triangles) and the sand filter (circles).
Ibuprofen and naproxen showed comparable removal rates among biomass that was attached to carriers and sand filter media and in suspended biomass (Figures 3 and S3). The 14CO2 formation rates were also similar between these two compounds, although ibuprofen tends to be more readily biotransformed,25,26 which may be due to the position of the 14C-labeling and the transformation pathways of the compounds. Naproxen has been observed to undergo O-demethylation, which targets the 14C-labeled position.27 In contrast, the parent degradation of ibuprofen occurs through several transformation reactions,28 which do not primarily target the 14C-labeled carboxylic group.
Diclofenac and mecoprop showed comparable removal rates for carrier-attached biomass and sand filter media, with slightly lower rates for activated sludge (Figures 3 and S3). The parent transformation of diclofenac has been reported to proceed at higher rates with the carrier-attached biofilm compared with suspended sludge.29,30 Several primary and secondary transformation products have also been identified, and one of the four primary transformation reactions targeted the 14C-labeled carboxylic group.31 The potential degradation pathways of mecoprop include the formation of 4-chloro-2-methylphenol and 4-chloro-2-methylphenol sulfate, and the partial transformation of the 14C-labeled phenolic ring structure has been demonstrated.32
The degradation rates of carbamazepine and sulfamethoxazole were low or negligible. For carbamazepine, the lack of 14CO2 formation that was observed in all experiments agrees with previous studies, in which no removal has been observed.33,34 For sulfamethoxazole, in contrast, the degradation of the parent compound has frequently been observed.35,36 However, the transformation pathways seldom include cleavage of the 14C-labeled aniline structure, as confirmed in studies examining 14C-labeled sulfamethoxazole and activated sludge.36,37 However, the degradation of the aniline structure has been reported during long-term incubations (>1 week) with bacterial strains that are isolated from suspended growth systems.38
The observed formation of 14CO2 did not fully match the observed decreases of 14C activity in the liquid phase (Figures 3 and S3). Similar observations have been reported for incubations with 14C-labeled micropollutants and soil,39 biofilm carriers,32 and sand filter media.19 Control experiments with carriers and acidification (pH 3) at the end of the incubation period resulted in no or negligible 14CO2 formation (<2% for all compounds) from precipitated 14C-carbonate. The missing 14C in this study may be due to the adsorption of transformation products or the incorporation of 14C into the biomass,18 but was not confirmed via the analysis of solid-phase 14C activities.
3.1.2. GAC-Filter Media
The results of the degradation and adsorption experiments performed using four concentrations of GAC (0.8, 3.5, 12, and 51 gTS/L) are summarized in Figure 4, with 14C activities divided between the CO2 trap (left panels), the liquid phase (middle panels), and the liquid phase of the heat-treated control (right panels). The absence of 14CO2 formation in heat-treated GAC controls (Figure S4) indicated that the observed decreases in 14C activities were due to the adsorption of micropollutants. In experiments with the lowest doses of heat-treated GAC, the activity in the liquid phase decreased continuously throughout the experiment, indicating that the observed adsorption profiles were affected by both the adsorption capacity and the adsorption kinetics.
Figure 4.
Partitioning of 14C activities between CO2 traps (red, left panel) and liquid phases (blue, middle panel) for six 14C-labeled micropollutants in contact with four different concentrations of GAC-filter media (0.8, 3.5, 12, and 51 gTS/L). The liquid phases of the corresponding heat-treated GAC controls are also shown (purple, right panel).
The highest affinity for adsorption onto GAC was observed for carbamazepine, followed by diclofenac and naproxen, and lower affinity for ibuprofen, sulfamethoxazole, and mecoprop. These adsorption patterns are similar to previous results on tertiary PAC treatment, which demonstrated a high level of adsorption for carbamazepine and lower levels of adsorption for sulfamethoxazole and mecoprop.1,40
In the experiments containing biologically active GAC, decreasing 14C activities in the liquid phase were accompanied by the formation of 14CO2 for four of the six tested micropollutants (left panel, Figure 4). Degradation, therefore, appears to contribute to the removal of ibuprofen, naproxen, diclofenac, and, to some extent, mecoprop. The formation of 14CO2 was observed for ibuprofen, naproxen, and diclofenac in all biologically active GAC experiments, and the formation rates generally increased with higher GAC concentrations, as expected due to the increasing amount of GAC-attached biofilm. These three compounds were also transformed in the experiments performed using biofilms attached to carriers and sand filter media (Figure 3). By comparing removal efficiencies between biologically activate and sterilized GAC filters, Rattier et al.14 indicated an additional biological removal of 10–20% for the same compounds. The degradation of these three compounds has further been demonstrated by individual γ proteobacteria that has been isolated from a GAC biofilm.41 For mecoprop, 14CO2 formation was only detectable at the highest GAC concentrations but remained below 10%.
The transformation of sulfamethoxazole and carbamazepine could not be detected via the formation of 14CO2. The declining 14C activities in the liquid phase that were observed for sulfamethoxazole and carbamazepine, therefore, appear to be associated with adsorption only. Although carbamazepine is considered to be readily adsorbed42 and practically nondegradable,43 the degradation of sulfamethoxazole has been indirectly demonstrated previously using GAC-filter media.16 As discussed previously, the absence of 14CO2 formation may be associated with the location of the 14C-labeled moiety.
The GAC-bound biofilm was capable of partially degrading the same substances as those degraded by other biofilm processes. A direct comparison of degradation rates between biofilm systems could not be performed due to the unknown biomass concentrations in the GAC experiments. However, the lowest GAC concentration (0.8 g/L) had a lower total weight (GAC + biomass) than the biomass carriers and sand filter media (1.2 gVS/L) but was still able to degrade diclofenac to a greater extent. These results indicated that the GAC biofilm was more efficient for diclofenac degradation than the MBBR carrier and sand filter biofilms. Based on these observations, it appears interesting to further explore the degradation capability of organic micropollutants by the GAC-bound biofilm and to compare degradation rates with other biofilms in a quantitative manner (e.g., using ATP44,45 or phospholipid analysis46,47).
When liquid phase 14C activities in biologically active reactors were compared with heat-treated GAC controls (middle panel and right panel, Figure 4), more rapid adsorption of liquid-phase 14C activities was generally observed in heat-treated controls, as illustrated by the faster removal of all substances at high GAC doses (particularly for nondegradable carbamazepine). The higher affinity for adsorption was likely caused by the heat-induced desorption of organic matter from the GAC during the sterilization (85 °C, 60 min) phase, liberating additional adsorption sites and/or decreasing mass transfer resistance. As a result, comparisons between the liquid-phase concentrations could not be used to estimate the overall contribution of biological degradation. However, experiments using the lowest doses of biologically active GAC (0.8 g/L) demonstrated larger decreases of 14C activities in the liquid phase for ibuprofen and naproxen compared with the corresponding controls (Figure S4), demonstrating that biological activity increased the overall removal of these pollutants. For higher GAC doses, similar comparisons could not be performed, as the decrease in liquid-phase concentrations always approached 100%.
For biologically active GAC reactors, the decrease of the 14C activity in the liquid phase was always more rapid than the corresponding 14CO2 formation, indicating that adsorption was faster than degradation and that previously adsorbed micropollutants could be degraded at a later time point. The latter phenomenon was particularly notable for diclofenac and could be observed by comparing 14C partitioning after 8 h (liquid: 22%; gas: 8%; remaining: 70%) with the corresponding values at the end of the experiment (liquid: 1%; gas: 80%; remaining: 19%). However, some delay in the mass transfer of 14CO2 from the liquid phase to the CO2 trap may also occur.
3.2. Degradation of Previously Adsorbed Micropollutants
To further investigate possible interactions between adsorption, desorption, and degradation, an experiment was designed that included a 24 h anaerobic adsorption phase and a subsequent aerobic desorption and degradation phase. Analysis after the anaerobic adsorption phase indicated that the majority of the 14C activities were adsorbed to the GAC, with less than 6% detected in CO2 traps (Table S2). The restricted degradation of the targeted micropollutants during anaerobic conditions is further supported by previous studies examining the parent compounds, except for sulfamethoxazole.48−50 After the anaerobic adsorption phase, the GAC, including adsorbed micropollutants, was separated from the liquid phase and transferred to a new aerobic reactor containing 14C-free wastewater.
Figure 5 displays the extent of 14CO2 formation for the previously adsorbed micropollutants. The results showed that the previously adsorbed ibuprofen and diclofenac could be degraded to 46 and 68%, respectively, illustrating that the mechanisms of removal can occur through the initial adsorption of the compounds followed by their subsequent degradation. Initial desorption could be observed by the increased 14C activity in the liquid phase. Whether this initial desorption is a prerequisite for subsequent degradation, however, could not be determined. Nonetheless, the results showed that initial adsorption, followed by degradation, is a possible mechanism for the removal of diclofenac and ibuprofen in GAC filters.
Figure 5.
Partitioning of 14C activities between the liquid phases (blue) and CO2 traps (red) for four previously adsorbed (24 h, anaerobic conditions, 12 g/L GAC) 14C-labeled micropollutants.
No degradation of previously adsorbed naproxen could, however, be observed after the anaerobic adsorption phase. The lack of CO2 formation observed in this GAC experiment was probably not caused by anaerobic inactivation of the biofilm, as the aerobic degradation of naproxen with carriers proceeded at the same rate regardless of the anaerobic pre-exposure (Section S9 and Figure S6). Limited desorption or availability of previously adsorbed naproxen could be an explanation for the lack of degradation, which might be supported by the ceasing 14CO2 formation as liquid-phase activities approached zero, as shown in Figure 4.
3.3. Implications
With respect to the study of biological degradation in GAC processes, the tracking of 14C in 14C-labeled micropollutants can circumvent some of the inherent limitations of other methods using LC-MS/MS analysis. For instance, estimating the removal of parent compounds through influent–effluent measurements cannot itself explain biological degradation,13 and the detection of biological transformation products may be prevented by their potential adsorption onto the activated carbon. While extraction of previously adsorbed micropollutants has been demonstrated,51,52 estimating biological contribution based on transformation product extraction still requires extensive knowledge on potential degradation pathways. Furthermore, the inhibition methods used to compare biologically active and sterilized GAC filters15,53 may not, selectively or completely,14 inhibit biological processes, and observed differences are still difficult to link directly to biological degradation of micropollutants, due to potential changes in activated carbon adsorption capacity induced by degradation of competing natural organic matter.
Despite the advantages of the 14C approach, this technique has its own limitations. The applied method can only demonstrate degradation through mineralization (to 14CO2) of labeled 14C-moieties, whereas the partial degradation of 14C-labeled moieties, or any partial/complete mineralization of any nonradiolabeled moieties, will pass unnoticed. Nonetheless, the method can enable direct confirmation of biological degradation through the formation of 14CO2 from 14C-labeled moieties as observed for diclofenac, mecoprop, ibuprofen, and naproxen and serve as a complement in future studies on concurrent adsorption and biodegradation in GAC filters.
With the degradation of previously adsorbed diclofenac and ibuprofen, our study has demonstrated the potential interaction between the two processes. This finding strengthens the hypothesis that the biological degradation in GAC filters is not limited by the hydraulic retention time. The potential decoupling of the hydraulic retention time from the micropollutant degradation time could be an important factor in the future design and operation of GAC systems.
Acknowledgments
This study was done within the project Less is more, which was financed by the Interreg South Baltic Programme 2014–2020 through the European Regional Development Fund (No. STHB.02.02.00-SE-0119/17) and by the Swedish Agency for Marine and Water Management (No. 2243-17). The authors thank the staff at Kristianstad and Klippan WWTPs for their support and technical assistance and Lisa Giles, PhD, for copyediting of the manuscript.
Glossary
Abbreviations
- GAC
granular activated carbon
- PAC
powdered activated carbon
- MBBR
moving bed biofilm reactor
- EBCT
empty bed contact time
- WWTP
wastewater treatment plant
- IFAS
integrated fixed-film activated sludge
- SRT
sludge retention time
- COD
chemical oxygen demand
- BOD
biological oxygen demand
- TOC
total organic carbon
- BET
Brunauer–Emmett–Teller
- DO
dissolved oxygen
- UVA254
ultraviolet absorbance at 254 nm
- TS
total solids
- VS
volatile solids
- SS
suspended solids
- VSS
volatile suspended solids
- LC
liquid chromatography
- MS
mass spectrometry
Supporting Information Available
The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.est.1c02728.
Information on wastewater treatment plant configurations and anaerobic/anoxic control experiments with naproxen; tables show a summary of experimental parameters and additional details for the experiments with initial adsorption and subsequent degradation and anaerobic/anoxic control experiments; figures show 14C partitioning in experiments with 14C-labeled micropollutants for background control experiments, heat-treatment control experiments, anaerobic/anoxic control experiments, activated sludge experiments, and an additional figure with liquid phase 14C activities in GAC experiments with/without heat treatment (PDF)
Author Contributions
A.B. and P.F. designed the study. A.B, S.K., and P.F. performed the laboratory experiments and the liquid scintillation analysis. A.B. and S.K. analyzed the data. A.B, S.K, O.S, Å.D, M.C, and P.F. interpreted results. A.B. wrote the manuscript with contributions from S.K, O.S, Å.D, M.C., and P.F.
The authors declare no competing financial interest.
This paper was published on July 27, 2021. Due to production error, incorrect data appeared in the top left panel of Figure 5. The corrected version was reposted on July 30, 2021.
Supplementary Material
References
- Margot J.; Kienle C.; Magnet A.; Weil M.; Rossi L.; de Alencastro L. F.; Abegglen C.; Thonney D.; Chèvre N.; Schärer M.; Barry D. A. Treatment of Micropollutants in Municipal Wastewater: Ozone or Powdered Activated Carbon?. Sci. Total Environ. 2013, 461–462, 480–498. 10.1016/j.scitotenv.2013.05.034. [DOI] [PubMed] [Google Scholar]
- Frank J.; Ruhl A. S.; Jekel M. Impacts of Backwashing on Granular Activated Carbon Fi Lters for Advanced Wastewater Treatment. Water Res. 2015, 87, 166–174. 10.1016/j.watres.2015.09.020. [DOI] [PubMed] [Google Scholar]
- Corwin C. J.; Summers R. S. Scaling Trace Organic Contaminant Adsorption Capacity by Granular Activated Carbon. Environ. Sci. Technol. 2010, 44, 5403–5408. 10.1021/es9037462. [DOI] [PubMed] [Google Scholar]
- Meinel F.; Ruhl A. S.; Sperlich A.; Zietzschmann F.; Jekel M. Pilot-Scale Investigation of Micropollutant Removal with Granular and Powdered Activated Carbon. Water, Air, Soil Pollut. 2015, 226, 2260 10.1007/s11270-014-2260-y. [DOI] [Google Scholar]
- Weber W. Jr.; Pirbazari M.; Melson G. L. Biological Growth on Activated Carbon: An Investigation by Scanning Electron Microscopy. Environ. Sci. Technol. 1978, 12, 817–819. 10.1021/es60143a005. [DOI] [Google Scholar]
- Stewart P. S. Diffusion in Biofilms. J. Bacteriol. 2003, 185, 1485–1491. 10.1128/JB.185.5.1485-1491.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Simpson D. R. Biofilm Processes in Biologically Active Carbon Water Purification. Water Res. 2008, 42, 2839–2848. 10.1016/j.watres.2008.02.025. [DOI] [PubMed] [Google Scholar]
- Altmann J.; Rehfeld D.; Träder K.; Sperlich A.; Jekel M. Combination of Granular Activated Carbon Adsorption and Deep-Bed Filtration as a Single Advanced Wastewater Treatment Step for Organic Micropollutant and Phosphorus Removal. Water Res. 2016, 92, 131–139. 10.1016/j.watres.2016.01.051. [DOI] [PubMed] [Google Scholar]
- Sirotkin A. S.; Koshkina L. Y.; Ippolitov K. G. The BAC-Process for Treatment of Waste Water Containing Non-Ionogenic Synthetic Surfactants. Water Res. 2001, 35, 3265–3271. 10.1016/S0043-1354(01)00029-X. [DOI] [PubMed] [Google Scholar]
- Aktaş Ö.; Çeçen F. Bioregeneration of Activated Carbon: A Review. Int. Biodeterior. Biodegrad. 2007, 59, 257–272. 10.1016/j.ibiod.2007.01.003. [DOI] [Google Scholar]
- Reungoat J.; Escher B. I.; Macova M.; Keller J. Biofiltration of Wastewater Treatment Plant Effluent: Effective Removal of Pharmaceuticals and Personal Care Products and Reduction of Toxicity. Water Res. 2011, 45, 2751–2762. 10.1016/j.watres.2011.02.013. [DOI] [PubMed] [Google Scholar]
- Fundneider T.; Acevedo Alonso V.; Wick A.; Albrecht D.; Lackner S. Implications of Biological Activated Carbon Filters for Micropollutant Removal in Wastewater Treatment. Water Res. 2021, 189, 116588 10.1016/j.watres.2020.116588. [DOI] [PubMed] [Google Scholar]
- Bourgin M.; Beck B.; Boehler M.; Borowska E.; Fleiner J.; Salhi E.; Teichler R.; von Gunten U.; Siegrist H.; McArdell C. S. Evaluation of a Full-Scale Wastewater Treatment Plant Upgraded with Ozonation and Biological Post-Treatments: Abatement of Micropollutants, Formation of Transformation Products and Oxidation by-Products. Water Res. 2018, 129, 486–498. 10.1016/j.watres.2017.10.036. [DOI] [PubMed] [Google Scholar]
- Rattier M.; Reungoat J.; Gernjak W.; Joss A.; Keller J. Investigating the Role of Adsorption and Biodegradation in the Removal of Organic Micropollutants during Biological Activated Carbon Filtration of Treated Wastewater. J. Water Reuse Desalin. 2012, 2, 127–139. 10.2166/wrd.2012.012. [DOI] [Google Scholar]
- Wang H.; Ho L.; Lewis D. M.; Brookes J. D.; Newcombe G. Discriminating and Assessing Adsorption and Biodegradation Removal Mechanisms during Granular Activated Carbon Filtration of Microcystin Toxins. Water Res. 2007, 41, 4262–4270. 10.1016/j.watres.2007.05.057. [DOI] [PubMed] [Google Scholar]
- Sbardella L.; Comas J.; Fenu A.; Rodriguez-Roda I.; Weemaes M. Advanced Biological Activated Carbon Filter for Removing Pharmaceutically Active Compounds from Treated Wastewater. Sci. Total Environ. 2018, 636, 519–529. 10.1016/j.scitotenv.2018.04.214. [DOI] [PubMed] [Google Scholar]
- Popple T.; Williams J. B.; May E.; Mills G. A.; Oliver R. Evaluation of a Sequencing Batch Reactor Sewage Treatment Rig for Investigating the Fate of Radioactively Labelled Pharmaceuticals: Case Study of Propranolol. Water Res. 2016, 88, 83–92. 10.1016/j.watres.2015.09.033. [DOI] [PubMed] [Google Scholar]
- Falås P.; Jewell K. S.; Hermes N.; Wick A.; Ternes T. A.; Joss A.; Lund J. Transformation, CO 2 Formation and Uptake of Four Organic Micropollutants by Carrier-Attached Microorganisms. Water Res. 2018, 141, 405–416. 10.1016/j.watres.2018.03.040. [DOI] [PubMed] [Google Scholar]
- Hedegaard M. J.; Arvin E.; Corfitzen C. B.; Albrechtsen H. J. Mecoprop (MCPP) Removal in Full-Scale Rapid Sand Filters at a Groundwater-Based Waterworks. Sci. Total Environ. 2014, 499, 257–264. 10.1016/j.scitotenv.2014.08.052. [DOI] [PubMed] [Google Scholar]
- Speitel G. E.; Dovantzis K.; DiGiano F. A. Mathematical Modeling of Bioregeneration in GAC Columns. J. Environ. Eng. 1987, 113, 32–48. 10.1061/(asce)0733-9372(1987)113:1(32). [DOI] [Google Scholar]
- Speitel G. E.; Lu C. J.; Turakhia M.; Zhu X. J. Biodegradation of Trace Concentrations of Substituted Phenols in Granular Activated Carbon Columns. Environ. Sci. Technol. 1989, 23, 68–74. 10.1021/es00178a008. [DOI] [Google Scholar]
- Putz A. R. H.; Losh D. E.; Speitel G. E. Removal of Nonbiodegradable Chemicals from Mixtures during Granular Activated Carbon Bioregeneration. J. Environ. Eng. 2005, 131, 196–205. 10.1061/(asce)0733-9372(2005)131:2(196). [DOI] [Google Scholar]
- Edefell E.; Falås P.; Kharel S.; Hagman M.; Christensson M.; Cimbritz M.; Bester K. MBBRs as Post-Treatment to Ozonation: Degradation of Transformation Products and Ozone-Resistant Micropollutants. Sci. Total Environ. 2021, 754, 142103 10.1016/j.scitotenv.2020.142103. [DOI] [PubMed] [Google Scholar]
- Stevens-Garmon J.; Drewes J. E.; Khan S. J.; McDonald J. A.; Dickenson E. R. V. Sorption of Emerging Trace Organic Compounds onto Wastewater Sludge Solids. Water Res. 2011, 45, 3417–3426. 10.1016/j.watres.2011.03.056. [DOI] [PubMed] [Google Scholar]
- Abegglen C.; Joss A.; McArdell C. S.; Fink G.; Schlüsener M. P.; Ternes T. A.; Siegrist H. The Fate of Selected Micropollutants in a Single-House MBR. Water Res. 2009, 43, 2036–2046. 10.1016/j.watres.2009.02.005. [DOI] [PubMed] [Google Scholar]
- Joss A.; Zabczynski S.; Göbel A.; Hoffmann B.; Löffler D.; McArdell C. S.; Ternes T. A.; Thomsen A.; Siegrist H. Biological Degradation of Pharmaceuticals in Municipal Wastewater Treatment: Proposing a Classification Scheme. Water Res. 2006, 40, 1686–1696. 10.1016/j.watres.2006.02.014. [DOI] [PubMed] [Google Scholar]
- Quintana J. B.; Weiss S.; Reemtsma T. Pathways and Metabolites of Microbial Degradation of Selected Acidic Pharmaceutical and Their Occurrence in Municipal Wastewater Treated by a Membrane Bioreactor. Water Res. 2005, 39, 2654–2664. 10.1016/j.watres.2005.04.068. [DOI] [PubMed] [Google Scholar]
- Zwiener C.; Seeger S.; Glauner T.; Frimmel F. H. Metabolites from the Biodegradation of Pharmaceutical Residues of Ibuprofen in Biofilm Reactors and Batch Experiments. Anal. Bioanal. Chem. 2002, 372, 569–575. 10.1007/s00216-001-1210-x. [DOI] [PubMed] [Google Scholar]
- Zupanc M.; Kosjek T.; Petkovšek M.; Dular M.; Kompare B.; Širok B.; Blažeka Ž.; Heath E. Removal of Pharmaceuticals from Wastewater by Biological Processes, Hydrodynamic Cavitation and UV Treatment. Ultrason. Sonochem. 2013, 20, 1104–1112. 10.1016/j.ultsonch.2012.12.003. [DOI] [PubMed] [Google Scholar]
- Falås P.; Longrée P.; La Cour Jansen J.; Siegrist H.; Hollender J.; Joss A. Micropollutant Removal by Attached and Suspended Growth in a Hybrid Biofilm-Activated Sludge Process. Water Res. 2013, 47, 4498–4506. 10.1016/j.watres.2013.05.010. [DOI] [PubMed] [Google Scholar]
- Jewell K. S.; Falås P.; Wick A.; Joss A.; Ternes T. A. Transformation of Diclofenac in Hybrid Biofilm–Activated Sludge Processes. Water Res. 2016, 105, 559–567. 10.1016/j.watres.2016.08.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Casas M. E.; Nielsen T. K.; Kot W.; Hansen L. H.; Johansen A.; Bester K. Degradation of Mecoprop in Polluted Landfill Leachate and Waste Water in a Moving Bed Biofilm Reactor. Water Res. 2017, 121, 213–220. 10.1016/j.watres.2017.05.031. [DOI] [PubMed] [Google Scholar]
- Suarez S.; Lema J. M.; Omil F. Removal of Pharmaceutical and Personal Care Products (PPCPs) under Nitrifying and Denitrifying Conditions. Water Res. 2010, 44, 3214–3224. 10.1016/j.watres.2010.02.040. [DOI] [PubMed] [Google Scholar]
- Wick A.; Fink G.; Joss A.; Siegrist H.; Ternes T. A. Fate of Beta Blockers and Psycho-Active Drugs in Conventional Wastewater Treatment. Water Res. 2009, 43, 1060–1074. 10.1016/j.watres.2008.11.031. [DOI] [PubMed] [Google Scholar]
- Radjenović J.; Petrović M.; Barceló D. Fate and Distribution of Pharmaceuticals in Wastewater and Sewage Sludge of the Conventional Activated Sludge (CAS) and Advanced Membrane Bioreactor (MBR) Treatment. Water Res. 2009, 43, 831–841. 10.1016/j.watres.2008.11.043. [DOI] [PubMed] [Google Scholar]
- Achermann S.; Bianco V.; Mansfeldt C. B.; Vogler B.; Kolvenbach B. A.; Corvini P. F. X.; Fenner K. Biotransformation of Sulfonamide Antibiotics in Activated Sludge: The Formation of Pterin-Conjugates Leads to Sustained Risk. Environ. Sci. Technol. 2018, 52, 6265–6274. 10.1021/acs.est.7b06716. [DOI] [PubMed] [Google Scholar]
- Alvarino T.; Nastold P.; Suarez S.; Omil F.; Corvini P. F. X.; Bouju H. Role of Biotransformation, Sorption and Mineralization of 14C-Labelled Sulfamethoxazole under Different Redox Conditions. Sci. Total Environ. 2016, 542, 706–715. 10.1016/j.scitotenv.2015.10.140. [DOI] [PubMed] [Google Scholar]
- Bouju H.; Ricken B.; Beffa T.; Corvini P. F. X.; Kolvenbach B. A. Isolation of Bacterial Strains Capable of Sulfamethoxazole Mineralization from an Acclimated Membrane Bioreactor. Appl. Environ. Microbiol. 2012, 78, 277–279. 10.1128/AEM.05888-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dodgen L. K.; Li J.; Wu X.; Lu Z.; Gan J. J. Transformation and Removal Pathways of Four Common PPCP/EDCs in Soil. Environ. Pollut. 2014, 193, 29–36. 10.1016/j.envpol.2014.06.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Löwenberg J.; Zenker A.; Baggenstos M.; Koch G.; Kazner C.; Wintgens T. Comparison of Two PAC/UF Processes for the Removal of Micropollutants from Wastewater Treatment Plant Effluent: Process Performance and Removal Efficiency. Water Res. 2014, 56, 26–36. 10.1016/j.watres.2014.02.038. [DOI] [PubMed] [Google Scholar]
- Lu Z.; Sun W.; Li C.; Ao X.; Yang C.; Li S. Bioremoval of Non-Steroidal Anti-Inflammatory Drugs by Pseudoxanthomonas Sp. DIN-3 Isolated from Biological Activated Carbon Process. Water Res. 2019, 161, 459–472. 10.1016/j.watres.2019.05.065. [DOI] [PubMed] [Google Scholar]
- Altmann J.; Ruhl A. S.; Zietzschmann F.; Jekel M. Direct Comparison of Ozonation and Adsorption onto Powdered Activated Carbon for Micropollutant Removal in Advanced Wastewater Treatment. Water Res. 2014, 55, 185–193. 10.1016/j.watres.2014.02.025. [DOI] [PubMed] [Google Scholar]
- Joss A.; Keller E.; Alder A. C.; Göbel A.; McArdell C. S.; Ternes T.; Siegrist H. Removal of Pharmaceuticals and Fragrances in Biological Wastewater Treatment. Water Res. 2005, 39, 3139–3152. 10.1016/j.watres.2005.05.031. [DOI] [PubMed] [Google Scholar]
- Velten S.; Hammes F.; Boller M.; Egli T. Rapid and Direct Estimation of Active Biomass on Granular Activated Carbon through Adenosine Tri-Phosphate (ATP) Determination. Water Res. 2007, 41, 1973–1983. 10.1016/j.watres.2007.01.021. [DOI] [PubMed] [Google Scholar]
- Magic-Knezev A.; van der Kooij D. Optimisation and Significance of ATP Analysis for Measuring Active Biomass in Granular Activated Carbon Filters Used in Water Treatment. Water Res. 2004, 38, 3971–3979. 10.1016/j.watres.2004.06.017. [DOI] [PubMed] [Google Scholar]
- Zearley T. L.; Summers R. S. Removal of Trace Organic Micropollutants by Drinking Water Biological Filters. Environ. Sci. Technol. 2012, 46, 9412–9419. 10.1021/es301428e. [DOI] [PubMed] [Google Scholar]
- Wang J. Z.; Summers R. S.; Miltner R. J. Biofiltration Performance: Part 1, Relationship to Biomass. J. - Am. Water Works Assoc. 1995, 87, 55–63. 10.1002/j.1551-8833.1995.tb06465.x. [DOI] [Google Scholar]
- Zipper C.; Bolliger C.; Fleischmann T.; Suter M. J. F.; Angst W.; Müller M. D.; Kohler H. P. E. Fate of the Herbicides Mecoprop, Dichlorprop, and 2,4-D in Aerobic and Anaerobic Sewage Sludge as Determined by Laboratory Batch Studies and Enantiomer-Specific Analysis. Biodegradation 1999, 10, 271–278. 10.1023/A:1008396022622. [DOI] [PubMed] [Google Scholar]
- Achermann S.; Falås P.; Joss A.; Mansfeldt C. B.; Men Y.; Vogler B.; Fenner K. Trends in Micropollutant Biotransformation along a Solids Retention Time Gradient. Environ. Sci. Technol. 2018, 52, 11601–11611. 10.1021/acs.est.8b02763. [DOI] [PubMed] [Google Scholar]
- Alvarino T.; Suarez S.; Lema J. M.; Omil F. Understanding the Removal Mechanisms of PPCPs and the Influence of Main Technological Parameters in Anaerobic UASB and Aerobic CAS Reactors. J. Hazard. Mater. 2014, 278, 506–513. 10.1016/j.jhazmat.2014.06.031. [DOI] [PubMed] [Google Scholar]
- Chen P.; Sun M.; Zhu Z.; Zhang J.; Shen G. Optimization of Ultrasonic-Assisted Extraction for Determination of Polycyclic Aromatic Hydrocarbons in Biochar-Based Fertilizer by Gas Chromatography-Mass Spectrometry. Anal. Bioanal. Chem. 2015, 407, 6149–6157. 10.1007/s00216-015-8790-3. [DOI] [PubMed] [Google Scholar]
- Oesterle P.; Lindberg R. H.; Fick J.; Jansson S. Extraction of Active Pharmaceutical Ingredients from Simulated Spent Activated Carbonaceous Adsorbents. Environ. Sci. Pollut. Res. 2020, 27, 25572–25581. 10.1007/s11356-020-08822-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Paredes L.; Lema J. M.; Omil F.; Carballa M.; et al. Science of the Total Environment Understanding the Fate of Organic Micropollutants in Sand and Granular Activated Carbon Bio Fi Ltration Systems. Sci. Total Environ. 2016, 551–552, 640–648. 10.1016/j.scitotenv.2016.02.008. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.